Search - tctmd.com

Displaying 1 - 20 of 61

Sort: Relevancy | Date

News Daily News

CMS Greenlights Reimbursement for Renal Denervation Systems

L.A. McKeown

October 29, 2025

News Daily News

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

L.A. McKeown

July 15, 2025

News Daily News

Lost Chances: Medicare Analysis Says Preamputation Vascular Care Eludes Many

L.A. McKeown

January 16, 2025

News Daily News

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

L.A. McKeown

December 12, 2024

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Daily News

BP Reductions Last 5 Years After Bariatric Surgery: GATEWAY

Michael O'Riordan

February 07, 2024

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

News Daily News

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

L.A. McKeown

August 23, 2023

News Daily News

As Renal Denervation Heads to Advisory Review, FDA Sets Out Key Questions

L.A. McKeown

August 18, 2023

News Daily News

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

L.A. McKeown

March 29, 2023

News Daily News

BP Reduction With Renal Denervation Still Evident a Decade On

Michael O'Riordan

January 31, 2023

News Daily News

Reduction in BP Drives Treatment Preference for Hypertensive Patients

Michael O'Riordan

December 20, 2022

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal Care Resumes

News Daily News

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Michael O'Riordan

October 18, 2022

News Daily News

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Michael O'Riordan

August 18, 2022

News Daily News

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Caitlin E. Cox

December 28, 2021

News Daily News

Predictors of AF May Help Guide Care After Stroke of Unknown Cause

Caitlin E. Cox

October 26, 2021

News Daily News

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

L.A. McKeown

August 10, 2021

News Daily News

People Age 90-Plus Do Fine With EVAR

Todd Neale

April 13, 2021

News Daily News

New Advanced Training Outlined for Future Vascular Medicine Specialists

Michael O'Riordan

January 21, 2021

Advertisement

CMS Greenlights Reimbursement for Renal Denervation Systems

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

Lost Chances: Medicare Analysis Says Preamputation Vascular Care Eludes Many

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

Scientific Statement Reviews Current Antithrombotic Options in PAD

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

BP Reductions Last 5 Years After Bariatric Surgery: GATEWAY

Top Endovascular News of 2023

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

As Renal Denervation Heads to Advisory Review, FDA Sets Out Key Questions

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

BP Reduction With Renal Denervation Still Evident a Decade On

Reduction in BP Drives Treatment Preference for Hypertensive Patients

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Predictors of AF May Help Guide Care After Stroke of Unknown Cause

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

People Age 90-Plus Do Fine With EVAR

New Advanced Training Outlined for Future Vascular Medicine Specialists

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content